Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,757 | 32,760 | 46,478 | 16,555 | 18,318 |
| Marketable Securities | 4,494 | 7,205 | N/A | N/A | 9,722 |
| Receivables | 20,144 | 23,222 | 27,801 | 20,338 | 17,977 |
| Inventories | 12,374 | 11,276 | 10,367 | 11,974 | 12,713 |
| Other current assets | 1,811 | 2,555 | 4,032 | 1,175 | 1,336 |
| TOTAL | $64,580 | $77,018 | $88,678 | $50,042 | $60,066 |
| Non-Current Assets | |||||
| PPE Net | 7,636 | 7,532 | 7,914 | 8,047 | 8,269 |
| Intangibles | 13,619 | 14,016 | 14,616 | 15,042 | 15,507 |
| Other Non-Current Assets | 3,423 | 3,530 | 149 | 149 | 150 |
| TOTAL | $24,678 | $25,078 | $22,679 | $23,238 | $23,926 |
| Total Assets | $89,258 | $102,096 | $111,357 | $73,280 | $83,992 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,372 | 8,615 | 8,557 | 16,019 | 15,983 |
| Accounts payable and accrued liabilities | 6,556 | 8,552 | 12,730 | 7,503 | 6,060 |
| Accrued Expenses | 33,684 | 34,118 | 35,818 | 29,947 | 34,128 |
| TOTAL | $57,218 | $51,856 | $57,105 | $53,469 | $56,171 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,489 | 43,266 | 43,217 | 43,892 | 43,932 |
| Other Non-Current Liabilities | 5,163 | 5,846 | 2,201 | 1,544 | 1,489 |
| TOTAL | $33,652 | $49,112 | $46,407 | $46,448 | $46,457 |
| Total Liabilities | $90,870 | $100,968 | $103,512 | $99,917 | $102,628 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,730 | 49,723 | 49,711 | 29,676 | 29,674 |
| Common Shares | 50 | 50 | 50 | 30 | 29 |
| Retained earnings | -328,346 | -324,583 | -316,983 | -307,646 | -294,951 |
| Other shareholders' equity | -351 | -353 | -352 | -352 | -351 |
| TOTAL | $-1,612 | $1,128 | $7,845 | $-26,637 | $-18,636 |
| Total Liabilities And Equity | $89,258 | $102,096 | $111,357 | $73,280 | $83,992 |